by Strados Labs | Oct 7, 2024 | Blog, Blog - Healthcare Focus
Dr. Henry Schmidt was the principal investigator for Strados Labs’ recent pediatric asthma study in partnership with Ann and Robert H. Lurie Children’s Hospital of Chicago which was completed earlier this year. The Strados team was fortunate to meet for a short...
by Strados Labs | Sep 27, 2024 | Blog, Blog - Healthcare Focus
Respiratory Therapy Magazine recently sat down with Nick Delmonico, CEO of Strados Labs, to discuss the RESP® Biosensor, an innovative wearable device designed to continuously capture lung sounds such as coughs, wheeze, and crackles. In this Q&A, Delmonico shares...
by Rachel Hollatz, RRT, RPSGT | Sep 10, 2024 | Blog, Blog - Healthcare Focus
Chronic Obstructive Pulmonary Disease (COPD), a combination of chronic bronchitis and emphysema that affects the respiratory system, can lead to certain adventitious (or abnormal) lung sounds often associated with exacerbations. While these sounds may be alarming,...
by Yu Kan Au, MD | Jun 10, 2024 | Blog, Blog - Clinical Trial Focus
The Leicester Cough Questionnaire (LCQ)1 is a self-reporting tool developed by S.S. Birring and others to evaluate the impact of chronic cough on a patient’s quality of life. Chronic cough,2 which impacts between 10-20% of the US population,3 is a cough that can...
by Shane Krauss | Mar 19, 2024 | Blog, Blog - Clinical Trial Focus
In November 2023, Merck’s chronic cough drug, gefapixant, faced a decisive setback from the FDA Advisory Committee. The concerns highlighted insufficient evidence for the drug providing a clinically meaningful benefit to adults with refractory chronic cough...
by Strados Labs | Feb 27, 2024 | Blog, Blog - Clinical Trial Focus
24-hour cough frequency has traditionally been recognized as the ‘gold standard’ primary endpoint for indications such as refractory chronic cough, chronic bronchitis, and IPF-related cough. While frequency is undoubtedly a valuable metric to measure for cough, there...
